All News

Finance & Investment

Top 10 Events in Cell & Gene Therapy 2022
18 January 2023
Top 10 Events in Cell & Gene Therapy 2022
It’s day 1 of Advanced
Merit Complete UK’s First CAR-T Cell Manufacturing Facility for Autolus Therapeutics
20 December 2022
Merit Complete UK’s First CAR-T Cell Manufacturing Facility for Autolus Therapeutics
Leading offsite engineering and construction
Arcellx and Kite Announce Collaboration to Develop CAR-T for Multiple Myeloma
14 December 2022
Arcellx and Kite Announce Collaboration to Develop CAR-T for Multiple Myeloma
Global pharmaceutical company, Kite, a
Commercial Considerations in the World of Rare Diseases
5 December 2022
Commercial Considerations in the World of Rare Diseases
For this interview, Phacilitate’s Becky
POPULAR NEWS ITEMS
Image
3 February 2023

Navigating the Applications of Title21’s Manufacturing Execution System

Image
2 February 2023

ScaleReady Demonstrate Cue – A Platform for Small Volume Cell Processing

Image
1 February 2023

NICE Approves CAR-T as NHS Treatment for Aggressive Forms of Blood Cancer

Merck and Moderna Announce Plans to Develop mRNA Personalized Cancer Vaccine
13 October 2022
Merck and Moderna Announce Plans to Develop mRNA Personalized Cancer Vaccine
Science and technology company Merck
AmplifyBio Acquires PACT Pharma to Advance Cell and Gene Therapy Services
4 October 2022
AmplifyBio Acquires PACT Pharma to Advance Cell and Gene Therapy Services
The contract and research organization
bluebird bio Receives Second FDA Approval for a Gene Therapy in Two Months with Skysona for CALD
20 September 2022
bluebird bio Receives Second FDA Approval for a Gene Therapy in Two Months with Skysona for CALD
bluebird bio’s Skysona has become
Capstan Therapeutics – Spin-Out from Penn University Launches with $165 Million to Deliver in vivo CAR-T
20 September 2022
Capstan Therapeutics – Spin-Out from Penn University Launches with $165 Million to Deliver in vivo CAR-T
Biotechnology company Capstan Therapeutics has
Load more News
RECOMENDED TOPICS
Clinical Trials
Collaborations, Mergers & Acquisitions
Finance & Investment
Patient Access & Engagement
Regulatory & Standards
Reimbursement
Strategy
POPULAR NEWS ITEMS
Image

Navigating the Applications of Title21’s Manufacturing Execution System

Image

ScaleReady Demonstrate Cue – A Platform for Small Volume Cell Processing

Image

NICE Approves CAR-T as NHS Treatment for Aggressive Forms of Blood Cancer